logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
C

Cheng‐Yuan Peng

china medical university

47H指数
411论文数
1.0W被引数
收录论文 183
发表时间
logo
Machine Learning Model for Predicting Hepatocellular Carcinoma Development in Patients With Hepatitis B Virus-Related Cirrhosis Receiving Antiviral Therapy用于预测接受抗病毒治疗的乙型肝炎病毒相关肝硬化患者肝细胞癌发展的机器学习模型
errKaohsiung Journal of Medical Sciences
IF3.1
err2026-09-15
err0
errOAAI
errPao-Yuan Huang; Heng-Syu Lin; Cheng-Yuan Peng; Ruei-Hau Hsu; Chien-Hung Chen
err分享
err收藏
Absence of steatosis combined with cardiometabolic risk factors confers the highest hepatocellular carcinoma risk in treated chronic hepatitis B非脂肪变性合并 cardiometabolic 风险因素使经治疗的慢性乙型肝炎患者具有最高的肝细胞癌风险
errAnnals of Medicine
IF4.3
err2026-04-20
err0
errOAAI
errHung-Wei Wang; Hsueh-Chou Lai; Wei-Fan Hsu; Sheng-Hung Chen; Yi-Chun Kuo; Cheng-Yuan Peng
err分享
err收藏
Reply to the Letter on “Metabolic and liver stiffness measures for hepatocellular carcinoma risk stratification after viral eradication in chronic hepatitis C”对“病毒清除后慢性丙型肝炎中代谢和肝脏硬度指标对肝细胞癌风险分层的信函回复”
errJournal of the Formosan Medical Association
IF2.5
err2026-04-12
err0
errOAAI
errSheng-Hung Chen; Cheng-Yuan Peng
err分享
err收藏
Reply to the letter on “Metabolic and liver stiffness measures for hepatocellular carcinoma risk stratification after viral eradication in chronic hepatitis C”回复关于“病毒清除后慢性丙型肝炎中代谢和肝脏硬度指标对肝细胞癌风险分层的信函”
errJournal of the Formosan Medical Association
IF2.5
err2026-04-12
err0
errOAAI
errSheng-Hung Chen; Cheng-Yuan Peng
err分享
err收藏
Reply to the letter on “metabolic and liver stiffness measures for hepatocellular carcinoma risk stratification after viral eradication in chronic hepatitis C”回复关于“病毒清除后慢性丙型肝炎中代谢和肝脏硬度指标对肝细胞癌风险分层的信函”
errJournal of the Formosan Medical Association
IF2.5
err2026-04-12
err0
errOAAI
errSheng-Hung Chen; Cheng-Yuan Peng
err分享
err收藏
Metabolic and liver stiffness measures for hepatocellular carcinoma risk stratification after viral eradication in chronic hepatitis C病毒清除后慢性丙型肝炎中代谢指标和肝硬度测量对肝细胞癌的风险分层
errJournal of the Formosan Medical Association
IF2.5
err2026-03-05
err0
errOAAI
errSheng-Hung Chen; Hsueh-Chou Lai; Wei-Fan Hsu; Hung-Wei Wang; Cheng-Yuan Peng
err分享
err收藏
qHBsAg outperforms ALT/qHBsAg ratio in predicting HBsAg seroclearance after cessation of entecavir versus tenofovirqHBsAg在预测停用恩替卡韦与替诺福韦后HBsAg血清清除方面优于ALT/qHBsAg比值。
errBiomedical Journal
IF4.4
err2026-01-13
err0
errOAAI
errHsing-Yun Lee; Cheng-Yuan Peng; Kwong-Ming Kee; Tsung-Hui Hu; Jing-Houng Wang; Chao-Hung Hung; Sheng-Nan Lu; Chien-Hung Chen
err分享
err收藏
Clinical implications of fibrosis marker dynamics after hepatitis C cure: Insights from paired biopsies丙肝治愈后纤维化标志物动态变化的临床意义：来自配对活检的见解
errJournal of the Formosan Medical Association
IF2.5
err2026-01-02
err0
errOAAI
errHung-Wei Wang; Hsueh-Chou Lai; I-Ping Chiang; Chia-Lin Huang; Sheng-Hung Chen; Te-Hong Chen; Wei-Fan Hsu; Cheng-Yuan Peng
err分享
err收藏
Gymconopin C exhibits anti-non-small cell lung cancer effect by regulating miR-6777-5p/ADRB2 pathway to promote mitophagyGymconopin C通过调节miR-6777-5p/ADRB2通路来促进线粒体自噬，从而发挥抗非小细胞肺癌作用。
errJournal of Advanced Research
IF13
err2025-12-19
err0
errOAAI
errXue Li; Mingyu Han; Limei Zhang; Xiaofang Xie; Chenying Li; Heng Zhang; Junsha An; Jianning Yang; Shuang Pu; Yue Duan; Changnian Yang; Cheng Peng; Hailin Tang; Fu Peng
err分享
err收藏
Corrigendum to “Peginterferon-alpha-2a add-on to treatment with siRNA JNJ-73763989 in virologically suppressed chronic hepatitis B: The phase II PENGUIN study” [JHEP Reports 2025 7(10) 101516]勘误：“Peginterferon-alpha-2a add-on to treatment with siRNA JNJ-73763989 in virologically suppressed chronic hepatitis B: The phase II PENGUIN study” [JHEP Reports 2025 7(10) 101516]
errJHEP Reports
IF7.5
err2025-11-24
err0
errOAAI
errEdward Gane; Ewa Janczewska; Tetsuo Takehara; Wan-Long Chuang; Cheng-Yuan Peng; Maria Hlebowicz; Yasuhiro Asahina; Ting-Tsung Chang; Ronald Kalmeijer; John Jezorwski; Gloria Kim; Zacharias Anastasiou; Thomas N. Kakuda; Thierry Verbinnen; Nonko Pehlivanov; Adam Bakala; Oliver Lenz; Michael Biermer
err分享
err收藏
Predictive Value of Serum Mac-2 Binding Protein Glycosylation Isomer for Hepatic Fibrosis in Hepatitis C Virus-Infected Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease血清Mac-2结合蛋白糖化异构体对代谢功能障碍相关脂肪性肝病合并丙型肝炎病毒感染患者肝纤维化的预测价值
errJOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
IF3.4
err2025-11-01
err0
PREAI
errChen, Yun-Chu; Chang, Yu-Ping; Lee, Ji-Yuh; Chen, Chi-Yi; Kao, Wei--Yu; Lin, Chih-lin; Yang, Sheng-shun; Shih, Yu-Lueng; Peng, Cheng-yuan; Lee, Fu-jen; Tsai, Ming-chang; Huang, Shang-Chin; Su, Tung-hung; Tseng, Tai-Chung; Liu, Chun-Jen; Chen, Pei-Jer; Kao, Jia-Horng; Liu, Chen-hua
err分享
err收藏
FAM83A is a prognostic biomarker for lung squamous cell carcinoma and correlated with immunoregulationFAM83A是肺鳞状细胞癌的预后生物标志物，并与免疫调节相关。
errScientific Reports
IF3.9
err2025-10-21
err0
errOAAI
errCheng Peng; Xuezhe Kong; Yuan Hui; Xiaoyuan Yang; Yun Hou; Wangwang Sheng; Jie Yuan; Xiang Fei; Kangwu Wang; Jingyu Nian; Weiguo Yu
err分享
err收藏
Prediction Model for Risk of Hepatocellular Carcinoma After Hepatitis C Viral Eradication丙型肝炎病毒清除后肝细胞癌风险的预测模型
errJournal of Hepatocellular Carcinoma
IF3.4
err2025-10-13
err0
errOAAI
errWei-Fan Hsu; Ching-Chu Lo; Kuo-Chih Tseng; Hsueh-Chou Lai; Chi-Yi Chen; Cheng-Yuan Peng
err分享
err收藏
Expert consensus on clinical usefulness of M2BPGi for managing chronic liver diseasesM2BPGi在慢性肝病管理中的临床应用专家共识
errJournal of the Formosan Medical Association
IF2.5
err2025-08-23
err0
errOAAI
errTai-Chung Tseng; Yao-Chun Hsu; Tung-Hung Su; Chen-Hua Liu; Chia-Chi Wang; Chih-Lin Lin; Hwai-I Yang; Yi-Hsiang Huang; Sheng-Shun Yang; Cheng-Yuan Peng; Tsung-Hui Hu; Jee-Fu Huang; Jia-Horng Kao
err分享
err收藏
Recombinant live attenuated measles virus-based vaccines inducing comprehensive protection against Ebola and Marburg viruses重组减毒麻疹病毒载体疫苗可诱导对埃博拉病毒和马尔堡病毒的全面保护
errMolecular Therapy
IF12
err2025-08-19
err0
PREAI
errJunhui Zhou; Xinghai Zhang; Yanfeng Yao; Ying Xie; Fangxu Li; Weiqi Wang; Feihu Yan; Cheng Peng; Baoyue Zhang; Yan Wu; Zengguo Cao; Yun Peng; Ge Gao; Huajun Zhang; Peng Gong; Sandra Chiu
err分享
err收藏
Components of cardiometabolic risk factors predict liver-related events in patients cured of hepatitis C Virus心血管代谢风险因素的成分可预测丙型肝炎病毒治愈患者的肝脏相关事件
errmicrobiology immunology and infection
IF0
err2025-07-30
err0
errOAAI
errWei-Fan Hsu; Hsueh-Chou Lai; Hung-Wei Wang; Sheng-Hung Chen; Wen-Pang Su; Hung-Yao Chen; Guan-Tarn Huang; Cheng-Yuan Peng
err分享
err收藏
Peginterferon-alpha-2a add-on to treatment with siRNA JNJ-73763989 in virologically suppressed chronic hepatitis B: the phase 2 PENGUIN study聚乙二醇干扰素-α-2a联合siRNA JNJ-73763989治疗病毒学抑制的慢性乙型肝炎：PENGUIN二期研究
errJHEP Reports
IF7.5
err2025-07-09
err0
errOAAI
errEdward Gane; Ewa Janczewska; Tetsuo Takehara; Wan-Long Chuang; Cheng-Yuan Peng; Maria Hlebowicz; Yasuhiro Asahina; Ting-Tsung Chang; Ronald Kalmeijer; John Jezorwski; Gloria Kim; Zacharias Anastasiou; Thomas N. Kakuda; Thierry Verbinnen; Nonko Pehlivanov; Adam Bakala; Oliver Lenz; Michael Biermer
err分享
err收藏
Effects of Sofosbuvir/Velpatasvir Therapy on Extrahepatic Manifestations in Patients With Type 2 Diabetes and Chronic Hepatitis C: Insights From a Nationwide Hepatitis C Virus Registry in TaiwanSofosbuvir/Velpatasvir治疗对2型糖尿病和慢性丙型肝炎患者肝外表现的影响: 来自台湾全国丙型肝炎病毒登记处的见解
errkaohsiung journal of medical sciences
IF0
err2025-06-20
err0
errOAAI
errSzu-Jen Wang; Te-Sheng Chang; Ching-Chu Lo; Chao-Hung Hung; Chien-Wei Huang; Lee-Won Chong; Pin-Nan Cheng; Ming-Jong Bair; Ming-Lun Yeh; Cheng-Yuan Peng; Chien-Yu Cheng; Jee-Fu Huang; Chih-Lang Lin; Chi-Chieh Yang; Hsing-Tao Kuo; Tsai-Yuan Hsieh; Tzong-Hsi Lee; Pei-Lun Lee; Wen-Chih Wu; Chih-Lin Lin; Wei-Wen Su; Sheng-Shun Yang; Chia-Chi Wang; Jui-Ting Hu; Lein-Ray Mo; Chun-Ting Chen; Yi-Hsiang Huang; Chun-Chao Chang; Chia-Sheng Huang; Guei-Ying Chen; Chien-Neng Kao; Chi-Ming Tai; Chun-Jen Liu; Mei-Hsuan Lee; Pei-Chien Tsai; Shu-Chi Wang; Chia-Yen Dai; Jia-Horng Kao; Han-Chieh Lin; Wang-Long Chuang; Kuo-Chih Tseng; Chi-Yi Chen; Chung-Feng Huang; Ming-Lung Yu
err分享
err收藏
Long-term risk of depression and the impact of risk factors among chronic hepatitis C patients after successful antiviral therapy: A nationwide real-world Taiwanese cohort (T-COACH)慢性丙型肝炎患者抗病毒治疗成功后抑郁症的长期风险及风险因素的影响：一项全国性真实世界台湾队列研究（T-COACH）
errJournal of the Formosan Medical Association
IF2.5
err2025-06-09
err0
errOAAI
errPing-Jen Hu; Ming-Lung Yu; Ming-Yao Chen; Chi-Yi Chen; Hsing-Tao Kuo; Chao-Hung Hung; Kuo-Chih Tseng; Hsueh-Chou Lai; Cheng-Yuan Peng; Jing-Houng Wang; Jyh-Jou Chen; Pei-Lun Lee; Rong-Nan Chien; Chi-Chieh Yang; Gin-Ho Lo; Jia-Horng Kao; Chun-Jen Liu; Chen-Hua Liu; Sheng-Lei Yan; Chun-Yen Lin
err分享
err收藏
Impact of Hepatitis C Virus Clearance on Cardiovascular Risk: A Real-World Experience From the Nationwide Taiwan Hepatitis C Virus Registry丙型肝炎病毒清除对心血管风险的影响: 来自全国台湾丙型肝炎病毒登记处的真实经验
errkaohsiung journal of medical sciences
IF0
err2025-05-24
err0
errOAAI
errPing-Jen Hu; Pei-Chien Tsai; Chi-Yi Chen; Hsing-Tao Kuo; Chao-Hung Hung; Kuo-Chih Tseng; Hsueh-Chou Lai; Cheng-Yuan Peng; Jing-Houng Wang; Jyh-Jou Chen; Pei-Lun Lee; Rong-Nan Chien; Chi-Chieh Yang; Gin-Ho Lo; Jia-Horng Kao; Chun-Jen Liu; Chen-Hua Liu; Sheng-Lei Yan; Chun-Yen Lin; Wei-Wen Su; Cheng-Hsin Chu; Chih-Jen Chen; Shui-Yi Tung; Chi-Ming Tai; Chih-Wen Lin; Ching-Chu Lo; Pin-Nan Cheng; Yen-Cheng Chiu; Chia-Chi Wang; Jin-Shiung Cheng; Wei-Lun Tsai; Han-Chieh Lin; Yi-Hsiang Huang; Ming-Lun Yeh; Chung-Feng Huang; Meng-Hsuan Hsieh; Jee-Fu Huang; Chia-Yen Dai; Wan-Long Chung; Yen-Hsiange Wang; Ming-Lung Yu; Ming-Jong Bair; T-COACH Study Group
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
M
Michael P. Manns
H 指数: 163 · 论文数: 2.1K
V
Vincent Wai‐Sun Wong
H 指数: 142 · 论文数: 1.2K
Z
Zobair M. Younossi
H 指数: 140 · 论文数: 1.5K
J
James C. Paulson
H 指数: 135 · 论文数: 556
S
Stefan Zeuzem
H 指数: 129 · 论文数: 2.3K
查看更多